| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/28/2005 | CA2552550A1 Piperidine derivatives as gcs inhibitors |
| 07/28/2005 | CA2552540A1 Use of substituted pteridines for the treatment of diseases of the respiratory tract |
| 07/28/2005 | CA2552539A1 Use of substituted pyrimido[5,4-d]pyrimidines for the treatment of respiratory diseases |
| 07/28/2005 | CA2552529A1 Use of ribose in recovery from anaesthesia |
| 07/28/2005 | CA2552524A1 Lipid compositions and methods of use |
| 07/28/2005 | CA2552521A1 Compositions comprosing memantine and polyanionic polymers for administration to the eye |
| 07/28/2005 | CA2552471A1 Combination of crf antagonists and 5-ht 1b receptor antagonists |
| 07/28/2005 | CA2552403A1 Benzimidazole derivatives |
| 07/28/2005 | CA2552027A1 Multi-nuclear metal complexes partially encapsulated by cucurbit[7-12]urils |
| 07/28/2005 | CA2552003A1 Methods for the production of sildenafil base and citrate salt |
| 07/28/2005 | CA2552002A1 Azabenzofuran substituted thioureas as inhibitors of viral replication |
| 07/28/2005 | CA2551948A1 Phenyl-[4-(3-phenyl-1h-pyrazol-4-yl)-pyrimidin-2-yl]-amine derivatives as igf-ir inhibitors |
| 07/28/2005 | CA2551869A1 Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activity |
| 07/28/2005 | CA2551770A1 2, 4 - diaminopyrimidines and their use for inducing cardiomyogenesis |
| 07/28/2005 | CA2551689A1 Memantine for the treatment of mild and mild-to-moderate alzheimer's disease |
| 07/28/2005 | CA2551639A1 (3-oxo-3, 4-dihydro-quinoxalin-2-yl-amino) -benzamide derivatives and related compound as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity |
| 07/28/2005 | CA2551415A1 Thiazole derivatives and use thereof |
| 07/28/2005 | CA2551128A1 Catalytic hydrogenation of nitriles to produce capsaicinoid derivatives and amine compounds, and methods for purifiying and obtaining the polymorphs thereof |
| 07/28/2005 | CA2551121A1 Crosslinked hyaluronic acid compositions for tissue augmentation |
| 07/28/2005 | CA2551119A1 Lipase inhibitor |
| 07/28/2005 | CA2550625A1 Nutrient compositions and methods for enhanced effectiveness of the immune system |
| 07/28/2005 | CA2548982A1 A process for the preparation of 4-(2-dipropylaminoethyl)-1,3-dihydro-2h-indol-2-one hydrochloride |
| 07/28/2005 | CA2547703A1 Bicyclic pyrazolo-fused compounds as protein kinase modulators |
| 07/28/2005 | CA2547394A1 New pharmaceutical compositions based on a scopineester and nicotinamide derivatives |
| 07/28/2005 | CA2547080A1 Heterocyclic protein kinase inhibitors and uses thereof |
| 07/28/2005 | CA2540272A1 Preventive or ameliorating agent for liver diseases associated with hepatopathy |
| 07/28/2005 | CA2456430A1 Improved process for the preparation of amorphous atorvastatin calcium |
| 07/27/2005 | EP1557670A1 REGULATION OF INTERACTION BETWEEN RAPL AND Rap1 |
| 07/27/2005 | EP1557472A1 Sodium chondroitin sulfate, chondroitin sulfate-containing material and processes for producing the same |
| 07/27/2005 | EP1557424A1 Bi-cyclic nucleoside, nucleotide and oligonucleoide analogues |
| 07/27/2005 | EP1557421A1 Polymorphous forms of rifaximin as antibiotics |
| 07/27/2005 | EP1557420A1 Process for producing optically active sulfoxide |
| 07/27/2005 | EP1557418A1 Novel quinoxaline derivatives |
| 07/27/2005 | EP1557417A1 Substituted 8'-pyri(mi)dinyl-dihydrospiro-[cycloalkylamine]-pyrimido[1,2a] pyrimidin-6-one derivatives |
| 07/27/2005 | EP1557416A1 Oxazolidinone-quinolone hybrid antibiotics |
| 07/27/2005 | EP1557415A1 Heterocyclic compounds and antitumor drugs containing the same as the active ingredient |
| 07/27/2005 | EP1557414A1 Isoquinoline compounds and medicinal use thereof |
| 07/27/2005 | EP1557412A1 Fluorinated benzothiadiazine derivatives and their use as AMPA receptor modulators |
| 07/27/2005 | EP1557411A1 N-phenyl-(2r,5s)dimethylpiperadine derivative |
| 07/27/2005 | EP1557410A2 Bacterial gyrase inhibitors and uses thereof |
| 07/27/2005 | EP1557409A1 5HT2C receptor modulators |
| 07/27/2005 | EP1557407A1 Novel alpha-ketoamide derivative and use thereof |
| 07/27/2005 | EP1557197A1 Dihydroalkoxybenzyloxopyrimidine (DABO) derivatives exhibiting spermicidal activity |
| 07/27/2005 | EP1557183A1 Local vascular delivery of mycophenolic acid in combination with rapamycin to prevent restenosis |
| 07/27/2005 | EP1557178A1 Use of sglt homolog |
| 07/27/2005 | EP1557170A2 Cellulose sulfate and other sulfated polysaccharides to prevent and treat papilloma virus infection and other infections |
| 07/27/2005 | EP1557169A1 Therapeutic and/or preventive agent for dyschezia |
| 07/27/2005 | EP1557167A1 Viral inhibition by long-chain alcohols alkanes fatty acids and amides |
| 07/27/2005 | EP1557166A1 Alpha-aminoamide derivatives useful in the treatment of lower urinary tract disorders |
| 07/27/2005 | EP1557165A1 Combination drug |
| 07/27/2005 | EP1557164A1 Adhesive patch containing tulobuterol |
| 07/27/2005 | EP1557163A1 Therapeutic causing contraction of mucosal tissue, method of treating diseases relating to mucosal tissues, injector and therapeutic set |
| 07/27/2005 | EP1557162A1 Transdermal patch for administering antihistamines |
| 07/27/2005 | EP1556513A2 Compositions and methods for treating human papillomavirus-mediated disease |
| 07/27/2005 | EP1556413A1 Methods and compositions for the treatment of ischemic reperfusion |
| 07/27/2005 | EP1556406A1 Derivatives comprising sterols and/or stanols and specific classes of anti-inflammatory agents and use thereof in treating or preventing cardiovascular disease |
| 07/27/2005 | EP1556401A2 22 human secreted proteins |
| 07/27/2005 | EP1556399A2 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
| 07/27/2005 | EP1556384A2 Pyrimido compounds having antiproliferative activity |
| 07/27/2005 | EP1556383A1 Process for preparing famciclovir |
| 07/27/2005 | EP1556382A1 3-phenyl substituted pyridoindolone, preparation and therapeutic use thereof |
| 07/27/2005 | EP1556381A1 Pyrazole amides for treating hiv infections |
| 07/27/2005 | EP1556379A2 Chemical compounds |
| 07/27/2005 | EP1556374A2 Benzopyranone compounds, compositions thereof, and methods for treating or preventing cancer |
| 07/27/2005 | EP1556371A2 Benzimidazole derivatives and their use as prodrugs of proton pump inhibitor |
| 07/27/2005 | EP1556369A1 Pyridazinone-derivatives as pde4 inhibitors |
| 07/27/2005 | EP1556363A2 Process for the preparation of valsartan and intermediates thereof |
| 07/27/2005 | EP1556362A2 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 07/27/2005 | EP1556357A1 Compounds, compositions, and methods |
| 07/27/2005 | EP1556356A1 Tetrahydroquinoline derivatives as crth2 antagonists |
| 07/27/2005 | EP1556354A2 Therapeutic piperazine derivates useful for treating pain |
| 07/27/2005 | EP1556353A1 Diaryl compounds as monoamine reuptake inhibitors |
| 07/27/2005 | EP1556352A1 Compounds capable of activating cholinergic receptors |
| 07/27/2005 | EP1556351A1 Secondary amino anilinic piperidines as mch1 antagonists and uses thereof |
| 07/27/2005 | EP1556349A1 1,4-disubstituted piperidine derivatives and their use as 11-betahsd1 inhibitors |
| 07/27/2005 | EP1556347A2 Gamma lactams as prostaglandin agonists and use thereof |
| 07/27/2005 | EP1556345A1 Vitamin d analogues, compositions comprising said analogues and their use |
| 07/27/2005 | EP1556342A1 Phenethanolamine derivative for the treatment of respiratory diseases |
| 07/27/2005 | EP1556339A2 Carboxyalkoxy-substituted acyl-carboxyphenyl-urea derivatives, production method and use thereof as medicine |
| 07/27/2005 | EP1556334A1 Cyclic nitromethyl acetic acid derivatives |
| 07/27/2005 | EP1556333A1 Hydroxyphenylundecane derivates, a process for their production and their use |
| 07/27/2005 | EP1556321A2 Policosanol compositions, extraction from novel sources, and uses thereof |
| 07/27/2005 | EP1556142A2 Alkyne derivatives as tracers for metabotropic glutamate receptor binding |
| 07/27/2005 | EP1556140A2 Novel compounds |
| 07/27/2005 | EP1556133A2 Transdermal delivery system for water insoluble drugs |
| 07/27/2005 | EP1556129A2 Compositions and methods for inducing osteogenesis |
| 07/27/2005 | EP1556085A2 Compounds for the treatment of metabolic disorders |
| 07/27/2005 | EP1556080A1 Use of convertase inhibitors in the treatment of fibrosis and scarring |
| 07/27/2005 | EP1556077A2 Use of cpg oligonucleotides in the treatment of hepatitis c virus infection |
| 07/27/2005 | EP1556075A2 Compositions for the treatment of autoimmune disorders |
| 07/27/2005 | EP1556073A2 Method and composition for preventing and treating solid tumors |
| 07/27/2005 | EP1556066A2 Compositions and methods of use for a fibroblast growth factor |
| 07/27/2005 | EP1556062A2 Herbal extract comprising a mixture of saponins obtained from sapindus trifoliatus for anticonvulsant activity |
| 07/27/2005 | EP1556059A1 Thrombopoietin mimetics |
| 07/27/2005 | EP1556058A1 Pharmaceutical compositions comprising estetrol derivatives for use in cancer therapy |
| 07/27/2005 | EP1556057A2 Agents and methods for enhancing bone formation |
| 07/27/2005 | EP1556056A2 X-nitro compounds, pharmaceutical compositions thereof and uses therof |
| 07/27/2005 | EP1556055A2 Use of cyclic nucleotide phosphodiesterase inhibitors having a benzodiazepine structure in therapy |
| 07/27/2005 | EP1556054A1 Antagonizing nk1 receptors inhibits consumption of substances of abuse |
| 07/27/2005 | EP1556053A1 Antiinflammation agents |